Complete Story
05/20/2026
Aetna
Policy Change
Effective May 1, 2026, we’ll no longer require precertification for Medicare fos:
Fulphila® (pegfilgrastim-jmdb) (Q5108)
Changes to commercial drug lists (found in OfficeLink below)
On July 1, 2026, we’ll update our pharmacy drug lists. These changes may include things like:
- Adding or removing specialty, brand-name and generic drugs
- Changing preferred or non-preferred drugs
- Changing prior authorization (PA), quantity limits and step therapy requirements
You’ll be able to view the changes as early as May 1, 2026. They’ll be on our Formularies and Pharmacy Clinical Policy Bulletins page.
Helpful Links
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!
